Urocortin, human

Urocortin, human is a synthetic peptide corresponding to the naturally occurring neuropeptide found in humans, belonging to the corticotropin-releasing factor (CRF) family. As a 40-amino acid peptide, it plays a crucial role in neuroendocrine signaling, stress response modulation, and the regulation of various physiological processes via its interaction with CRF receptors. Its structural similarity to CRF, combined with distinct receptor affinities, makes it a valuable tool for dissecting the molecular mechanisms underlying the hypothalamic-pituitary-adrenal (HPA) axis and related pathways. Urocortin's unique receptor selectivity and functional diversity have established it as an important molecule for advanced peptide research, receptor pharmacology, and neurobiology studies.

Peptide receptor characterization: Urocortin is extensively utilized in studies aimed at elucidating the pharmacological properties and signaling mechanisms of CRF receptors, particularly CRF-R1 and CRF-R2. By serving as a selective ligand, it enables researchers to differentiate receptor subtype responses, dissect downstream signaling cascades, and quantify receptor-ligand binding kinetics. Such investigations are fundamental for mapping receptor distribution, understanding ligand-receptor specificity, and exploring the physiological roles of CRF receptor subtypes in various tissues.

Neuroendocrine stress response research: The peptide's involvement in modulating the HPA axis positions it as a central probe for probing neuroendocrine stress mechanisms. Experimental models employing urocortin facilitate the assessment of peptide-induced changes in hormone secretion, neuronal activation, and feedback regulation within the stress axis. These studies provide critical insights into the molecular basis of stress adaptation, neuropeptide signaling, and cross-talk between neuroendocrine and peripheral systems.

Behavioral neuroscience: Urocortin is widely applied in behavioral research to investigate its effects on anxiety-like behaviors, feeding patterns, and social interactions in animal models. By administering the peptide centrally or peripherally, researchers can evaluate its influence on neural circuits governing emotional and motivational states. Such applications help delineate the neurochemical pathways through which CRF family peptides modulate complex behaviors, advancing the understanding of peptide-based signaling in the central nervous system.

Peptide structure-function analysis: As a well-characterized member of the CRF peptide family, urocortin serves as a reference compound for structure-activity relationship (SAR) studies. Researchers use synthetic analogs and modified sequences to probe the impact of specific amino acid substitutions on receptor affinity, peptide stability, and biological activity. These investigations contribute to the rational design of novel peptide ligands with tailored pharmacological profiles, supporting the development of new research tools and potential modulators of CRF receptor function.

Peptide synthesis and analytical validation: Urocortin is also employed as a standard in peptide synthesis validation and analytical method development. Its defined sequence and characterized properties make it suitable for calibrating chromatographic systems, optimizing purification protocols, and validating mass spectrometric detection techniques. These technical applications ensure the reliability and reproducibility of peptide production workflows, supporting broader research efforts in peptide chemistry and analytical biochemistry.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Myotropic activity of allatostatins in tenebrionid beetles

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis